Acute Myeloid LeukemiaPhase 1NCT03113643Papers
SL-401
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
83 Phase 1 studies recruiting right now, most recently updated first.
Open the Phase 2 page · a list of only those studies
Triangle is made by Triangle Health, Inc.
Leukemia, lymphoma, and myeloma83 studies
Acute Myeloid LeukemiaPhase 1NCT03113643Papers
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Multiple MyelomaPhase 1NCT04483206Papers
Personalized Autologous Transplant for Multiple Myeloma
Untreated Nodal T Follicular Helper Cell LymphomaPhase 1NCT07278856
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
Multiple MyelomaPhase 1NCT07581704
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
Central Nervous System LymphomaPhase 1NCT05625594
Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma
Recurrent Acute Lymphoblastic LeukemiaPhase 1NCT05418088
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
AML/MDSPhase 1NCT04318678Papers
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
Acute Myeloid Leukemia and Other Myeloid MalignanciesPhase 1/2NCT06928662
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse
Secondary CNS LymphomaPhase 1NCT06730542
Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma
Relapsed or Refractory T-Cell Non-Hodgkin LymphomaPhase 1/2NCT07225985
Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma
Multiple MyelomaPhase 1NCT07377435
DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM
Non Hodgkin LymphomaPhase 1/2NCT06768905
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
Acute Myeloid LeukemiaPhase 1NCT07374029
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
Large B-Cell Lymphoma (LBCL)Phase 1NCT07361224Papers
Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion
Acute Myeloid Leukemia and High-Grade Myeloid NeoplasmsPhase 1/2NCT04797767Papers
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
Relapsed or Refractory Multiple MyelomaPhase 1NCT07032714
Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma
B-cell Lymphoma RefractoryPhase 1/2NCT07319676Papers
Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas
Relapsed/Refractory Multiple MyelomaPhase 1/2NCT06536413Papers
ATRA and Carfilzomib in Plasma Cell Myeloma Patients
Relapsed or Refractory Hodgkin Lymphoma and CD30+ LymphomasPhase 1NCT05544968
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
Acute Myeloid LeukemiaPhase 1NCT03533816Papers
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Newly Diagnosed NPM1- and FLT3-Mutated AMLPhase 1NCT06313437
Revumenib in Combination With 7+3 + Midostaurin in AML
Relapsed or Refractory Acute Myeloid LeukemiaPhase 1NCT05627232
Tazemetostat and Palbociclib With CPX-351for R/R AML
High-Risk Large B-Cell Lymphoma After Cellular TherapyPhase 1/2NCT05256641
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
Acute Myeloid LeukemiaPhase 1NCT05748197Papers
ADCLEC.syn1 in People With Acute Myeloid Leukemia